Skip to main content

INGALLS & SNYDER LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1041885 NEW YORK, NY

Position in VRTX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,344,978
-$118,014 QoQ
Shares Held
3,012
-6.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

INGALLS & SNYDER LLC holds $352,579,823 across 11 Biotechnology names. VRTX ranks #5 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
3,012 $1,344,978

All Filings in VRTX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,344,978 3,012
2025-12-31 $1,462,992 3,227
2025-09-30 $1,259,122 3,215
2025-06-30 $1,462,036 3,284
2025-03-31 $1,611,541 3,324
2024-12-31 $1,204,073 2,990
2024-09-30 $460,429 990
2024-06-30 $434,503 927
2024-03-31 $431,804 1,033
2023-12-31 $420,317 1,033
2023-09-30 $349,130 1,004
2023-06-30 $353,317 1,004
2023-03-31 $316,330 1,004
2022-12-31 $289,935 1,004
2022-09-30 $290,698 1,004
2022-06-30 $282,917 1,004
2022-03-31 $263,840 1,011
2021-12-31 $221,137 1,007
2021-06-30 $203,041 1,007
2021-03-31 $257,868 1,200
2020-12-31 $283,608 1,200
2020-09-30 $326,544 1,200
2020-06-30 $348,372 1,200
2020-03-31 $868,517 3,650